Article info
PDFShort report
Duration of amantadine benefit on dyskinesia of severe Parkinson’s disease
- Correspondence to: Professor M Onofrj Neurophysiopathology, Movement Disorders Centre, Department of Oncology and Neuroscience, Università “G. D’Annunzio”; Chieti-Pescara, via Fonte Romana, 65124 Pescara, Italy; email: monofrjunich.it
Citation
Duration of amantadine benefit on dyskinesia of severe Parkinson’s disease
Publication history
- Received March 18, 2003
- Accepted May 29, 2003
- Revised May 27, 2003
- First published January 5, 2004.
Online issue publication
April 13, 2016
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
Copyright 2004 Journal of Neurology Neurosurgery and Psychiatry